Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0IJO stock hub

LON/0IJO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0IJOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

8.9B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0IJO

In the news

Latest news · LON/0IJO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.5

P25 12.9P50 16.9P75 23.5

Trailing P/E14.1

P25 15.9P50 22.9P75 35.8

ROE41

P25 -54.2P50 2.1P75 13.7

ROIC60.4

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0IJO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

220

Groups with data

Currency

USD

Showing 220 of 220 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	1,077
Employees Change	-70%
Employees Change Percent	-6.1
Enterprise value	$8B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US30161Q1040
Last refreshed	2026-05-10
Market cap	$8.9B
Price	$47.66
Price currency	USD
Rev Per Employee	1,670,353.96x
Sector	Healthcare
Sic	2836
Symbol	lon/0IJO
Website	https://www.exelixis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.1%
EV Earnings	12.61x
EV/EBIT	11.33x
EV/EBITDA	10.67x
EV/FCF	11.46x
EV/Sales	4.57x
FCF yield	7.82%
Forward P/E	12.46x
P/B ratio	6.06x
P/E ratio	14.08x
P/S ratio	4.94x
PE Ratio10 Y	62.12x
PE Ratio3 Y	26.51x
PE Ratio5 Y	28.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	40.29%
EBITDA Margin	41.5%
FCF margin	38.63%
Gross margin	96.44%
Gross Profit	$1.7B
Gross Profit Growth	2.98%
Gross Profit Growth Q	10.18%
Gross Profit Growth3 Y	12.6%
Gross Profit Growth5 Y	18.26%
Net Income	$631.2M
Net Income Growth	29.5%
Net Income Growth Q	31.86%
Net Income Growth Quarters	3%
Net Income Growth Years	3%
Net Income Growth3 Y	75.67%
Net Income Growth5 Y	66.69%
Pretax Margin	42.23%
Profit Margin	35.08%
Profit Per Employee	$586,030
Profitable Years	9
ROA	22.03
Roa5y	9.89
ROCE	43.07
ROE	40.99
Roe5y	17.29
ROIC	60.44
Roic5y	29.34

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	29.71%
Cagr3y	34.73%
Cagr5y	13.82%
EPS Growth	37.17
EPS Growth Q	43.64
EPS Growth Quarters	3
EPS Growth Years	3
EPS Growth3 Y	85.92
EPS Growth5 Y	71.26
FCF Growth	11.79%
FCF Growth Q	20.07%
FCF Growth3 Y	51.26%
FCF Growth5 Y	43.37%
OCF Growth	9.74%
OCF Growth Q	19.11%
OCF Growth10 Y	31.39%
OCF Growth3 Y	45.64%
OCF Growth5 Y	36.88%
Revenue Growth	3.33x
Revenue Growth Q	9.97x
Revenue Growth Quarters	3x
Revenue Growth Years	11x
Revenue Growth3 Y	12.6x
Revenue Growth5 Y	18.17x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.87
Assets	$2B
Cash	$588.6M
Current Assets	$886.6M
Current Liabilities	$272.1M
Debt	$128.4M
Debt EBITDA	$0.17
Debt Equity	$0.09
Debt FCF	$0.18
Equity	$1.5B
Liabilities	$498.2M
Long Term Assets	$1.1B
Long Term Liabilities	$226.1M
Net Cash	$951.8M
Net Cash By Market Cap	$10.71
Net Cash Growth	-14.13%
Net Debt EBITDA	$-1.27
Net Debt Equity	$-0.65
Net Debt FCF	$-1.37
Tangible Book Value	$1.4B
Tangible Book Value Per Share	$5.59
WACC	6.28

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.26
Inventory Turnover	3.28
Net Working Capital	$45.8M
Quick ratio	3.01
Working Capital	$634.4M
Working Capital Turnover	$1.96

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	5.19%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	29.69%
200-day SMA	41.69
3Y total return	144.6%
50-day SMA	43.46
50-day SMA vs 200-day SMA	50over200
5Y total return	90.98%
All Time High	51.98
All Time High Change	-8.31%
All Time High Date	2025-06-23
All Time Low	14.12
All Time Low Change	237.54%
All Time Low Date	2018-10-25
ATR	1.78
Beta	0.39
Ch YTD	8.37
High	47.79
High52	51.98
High52 Date	2025-06-23
High52ch	-8.31%
Low	46.03
Low52	33.81
Low52 Date	2025-10-20
Low52ch	40.96%
Ma50ch	9.66%
Price vs 200-day SMA	14.33%
RSI	61.2
RSI Monthly	65.54
RSI Weekly	63.4
Sharpe ratio	0.52x
Sortino ratio	0.91
Total Return	5.19%
Tr YTD	8.37
Tr1m	8.47%
Tr1w	8.09%
Tr3m	8.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$724.9M
Operating Income Growth	17.52
Operating Income Growth Q	34.51
Operating Income Growth3 Y	86.71
Operating Income Growth5 Y	78.62
Operating margin	40.29

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	203,072,463%
Shares Insiders	1.92%
Shares Institutions	88.77%
Shares Qo Q	-3.27%
Shares Yo Y	-5.19%
Short Ratio	10.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$607M
Average Volume	1,334.2x
Bv Per Share	5.78
CAPEX	$-5.3M
Ch1m	8.47
Ch1w	8.09
Ch1y	29.69
Ch3m	8.91
Ch3y	144.6
Ch5y	90.98
Ch6m	18.63
Change	3.83%
Change From Open	3.54
Close	45.9
Days Gap	0.28
Depreciation Amortization	21,021,044.2
Dollar Volume	216,376.4
Earnings Date	2026-05-05
EBIT	$724.9M
EBITDA	$746.6M
EPS	$2.29
F Score	5
FCF	$695M
FCF EV Yield	8.73x
Financing CF	-857,179,898
Fiscal Year End	December
Founded	1,994
Goodwill	46,713,105.6
Graham Number	24.47787
Graham Upside	-48.64
Income Tax	$128.6M
Investing CF	189,028,629
Is Primary Listing	0
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Lynch Fair Value	$84.65
Lynch Upside	77.61
Ma150	42.6
Ma150ch	11.87%
Ma20	45.17
Ma20ch	5.51%
Net CF	32,109,732
Open	46.03
P FCF Ratio	12.78
P OCF Ratio	12.69
Position In Range	92.61
Ppne	70,068,191.3
Price Date	2026-05-08
Price EBITDA	$11.9
Ptbv Ratio	6.27
Relative Volume	3.4x
Revenue	1,798,971,212x
SBC By Revenue	4.89x
Share Based Comp	87,925,382
Tax By Revenue	7.15x
Tax Rate	16.92%
Tr6m	18.63%
Volume	4,540
Z Score	12.52

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0IJO pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0IJO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0IJO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+88.8%

Share of float held by funds and institutions

Insider ownership

+1.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0IJO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.2

Neutral momentum band

Price vs 200-day MA

+14.3%

50/200-day relationship not available

Beta (5Y)

0.39

Less volatile than the market

Sharpe ratio

0.52

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0IJO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0IJO stock rating?

lon/0IJO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0IJO analysis?

The full report lives at /stocks/lon/0IJO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0IJO?

The latest report frames lon/0IJO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0IJO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.